Related references
Note: Only part of the references are listed.An improved syngeneic orthotopic murine model of human breast cancer progression
Omar M. Rashid et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Cancer Statistics, 2014
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2014)
Integrated Next-Generation Sequencing and Avatar Mouse Models for Personalized Cancer Treatment
Elena Garralda et al.
CLINICAL CANCER RESEARCH (2014)
Improving productivity of modern-day drug discovery
Matthew D. Breyer
EXPERT OPINION ON DRUG DISCOVERY (2014)
Fluorescently labeled chimeric anti-CEA antibody improves detection and resection of human colon cancer in a patient-derived orthotopic xenograft (PDOX) nude mouse model
Cristina A. Metildi et al.
JOURNAL OF SURGICAL ONCOLOGY (2014)
Hand-held high-resolution fluorescence imaging system for fluorescence-guided surgery of patient and cell-line pancreatic tumors growing orthotopically in nude mice
Yukihiko Hiroshima et al.
JOURNAL OF SURGICAL RESEARCH (2014)
Does Removal of the Primary Tumor in Metastatic Breast Cancer Improve Survival?
Omar M. Rashid et al.
JOURNAL OF WOMENS HEALTH (2014)
Resection of the primary tumor improves survival in metastatic breast cancer by reducing overall tumor burden
Omar M. Rashid et al.
SURGERY (2013)
Targeting the HER/EGFR/ErbB Family to Prevent Breast Cancer
Louise R. Howe et al.
CANCER PREVENTION RESEARCH (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
A Molecularly Annotated Platform of Patient-Derived Xenografts (Xenopatients) Identifies HER2 as an Effective Therapeutic Target in Cetuximab-Resistant Colorectal Cancer
Andrea Bertotti et al.
CANCER DISCOVERY (2011)
Genome remodelling in a basal-like breast cancer metastasis and xenograft
Li Ding et al.
NATURE (2010)
Long-term Cultures of Bone Marrow-Derived Human Mesenchymal Stem Cells Frequently Undergo Spontaneous Malignant Transformation (This article contains errors due to a cross contamination of the cell lines we used. To correct this issue we published a letter in Cancer Res. 2010 Aug 1,70(15),6393-6)
Gro Vatne Rosland et al.
CANCER RESEARCH (2009)
An improved model to study tumor cell autonomous metastasis programs using MTLn3 cells and the Rag2-/- γc-/- mouse
Sylvia E. Le Devedec et al.
CLINICAL & EXPERIMENTAL METASTASIS (2009)
Global Drug Discovery: Europe Is Ahead
Donald W. Light
HEALTH AFFAIRS (2009)
From Human to Mouse and Back: Tumorgraft Models Surge in Popularity
Ken Garber
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
In Vivo Bioluminescence Imaging Monitoring of Hypoxia-Inducible Factor 1 alpha, a Promoter That Protects Cells, in Response to Chemotherapy
Ronald J. Viola et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2008)
Imagable 4T1 model for the study of late stage breast cancer
Kai Tao et al.
BMC CANCER (2008)
Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors
Jason I. Herschkowitz et al.
GENOME BIOLOGY (2007)
Murine models to evaluate novel and conventional therapeutic strategies for cancer
James E. Talmadge et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Modeling metastatic breast cancer in mice
Jos Jonkers et al.
JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA (2007)
Tumor models for efficacy determination
Beverly A. Teicher
MOLECULAR CANCER THERAPEUTICS (2006)
From genetic abnormality to metastases: murine models of breast cancer and their use in the development of anticancer therapies
P. D. Ottewell et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
Estimating the cost of new drug development: Is it really $802 million?
CP Adams et al.
HEALTH AFFAIRS (2006)
CXCL-12/stromal cell-derived factor-1α transactivates HER2-neu in breast cancer cells by a novel pathway involving Src kinase activation
N Cabioglu et al.
CANCER RESEARCH (2005)
Genes that mediate breast cancer metastasis to lung
AJ Minn et al.
NATURE (2005)
Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion
A Orimo et al.
CELL (2005)
Orthotopic models of cancer for preclinical drug evaluation: advantages and disadvantages
MC Bibby
EUROPEAN JOURNAL OF CANCER (2004)
Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis
J Yang et al.
CELL (2004)
A urokinase-derived peptide (Å6) increases survival of mice bearing orthotopically grown prostate cancer and reduces lymph node metastasis
DD Boyd et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases
EY Lin et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Matrix metalloproteinases and their role in pancreatic cancer: A review of preclinical studies and clinical trials
M Bloomston et al.
ANNALS OF SURGICAL ONCOLOGY (2002)
Gene expression profiling predicts clinical outcome of breast cancer
LJ van't Veer et al.
NATURE (2002)
Antitumor effects of Flt3 ligand in transplanted murine tumor models
BJ Averbook et al.
JOURNAL OF IMMUNOTHERAPY (2002)
Building 'validated' mouse models of human cancer
B Hann et al.
CURRENT OPINION IN CELL BIOLOGY (2001)
Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials
JI Johnson et al.
BRITISH JOURNAL OF CANCER (2001)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
Share Paper
